data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
electroCore
(NASDAQ:ECOR)
$0.5099
0.0096[1.92%]
At close: Jun 30
$0.5003
-0.0096[-1.88%]
After Hours: 4:22PM EDT
Day High/Low0.48 - 0.52
52 Week High/Low0.27 - 1.3
Open / Close0.5 / 0.51
Float / Outstanding65.3M / 70.8M
Vol / Avg.136K / 304.5K
Mkt Cap36.1M
P/E-
50d Avg. Price0.47
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float65.3M

electroCore (NASDAQ:ECOR), Quotes and News Summary

electroCore (NASDAQ: ECOR)

Day High/Low0.48 - 0.52
52 Week High/Low0.27 - 1.3
Open / Close0.5 / 0.51
Float / Outstanding65.3M / 70.8M
Vol / Avg.136K / 304.5K
Mkt Cap36.1M
P/E-
50d Avg. Price0.47
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float65.3M
Benzinga - Jun 23, 2022, 8:03AM
Benzinga - May 10, 2022, 5:44AM
Benzinga - May 6, 2022, 12:51PM
Benzinga - May 6, 2022, 12:02PM
Benzinga - May 5, 2022, 4:17PM
Benzinga - May 5, 2022, 4:16PM
Benzinga - Apr 21, 2022, 8:01AM
Benzinga - Apr 19, 2022, 8:05AM
Benzinga - Apr 12, 2022, 8:09AM
Benzinga - Apr 5, 2022, 8:01AM
Benzinga - Mar 10, 2022, 4:04PM
Benzinga - Mar 7, 2022, 4:04PM
Benzinga - Mar 1, 2022, 11:44AM
Benzinga - Feb 22, 2022, 12:40PM
Benzinga - Feb 1, 2022, 8:01AM
Benzinga - Jan 25, 2022, 1:16PM
Benzinga - Jan 19, 2022, 6:32AM
Benzinga - Jan 18, 2022, 5:10PM
Benzinga - Jan 18, 2022, 9:32AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.070-0.080 -0.0100
REV1.770M1.899M129.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

electroCore Questions & Answers

Q
How do I buy electroCore (ECOR) stock?
A

You can purchase shares of electroCore (NASDAQ: ECOR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are electroCore's (ECOR) competitors?
Q
What is the target price for electroCore (ECOR) stock?
A

The latest price target for electroCore (NASDAQ: ECOR) was reported by HC Wainwright & Co. on Wednesday, January 19, 2022. The analyst firm set a price target for 2.75 expecting ECOR to rise to within 12 months (a possible 439.32% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for electroCore (ECOR)?
A

The stock price for electroCore (NASDAQ: ECOR) is $0.5099 last updated June 30, 2022, 8:00 PM UTC.

Q
Does electroCore (ECOR) pay a dividend?
A

There are no upcoming dividends for electroCore.

Q
When is electroCore (NASDAQ:ECOR) reporting earnings?
A

electroCore’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is electroCore (ECOR) going to split?
A

There is no upcoming split for electroCore.

Q
What sector and industry does electroCore (ECOR) operate in?
A

electroCore is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.